Recent developments
AI summary of recent coverageRecent coverage has focused on Paul Hudson's departure as Sanofi's chief executive, with the French pharmaceutical company announcing Belén Garijo, former CEO of Merck KGaA, as Hudson's replacement. The transition has been characterized in reporting as addressing a stalled turnaround at Sanofi, with commentary on Hudson's tenure highlighting both the success of the drug Dupixent and setbacks in research and development efforts. Coverage has also examined what strategic direction Garijo may pursue at the company going forward.
Summarized from the headlines below; see each source for the full story.
Key Facts
Source: Wikidata ↗- Born
- October 14, 1967 · Manchester
- Citizenship
- United Kingdom
- Education
- Manchester Metropolitan University
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Paul Hudson, it will appear here — and tie into the news timeline.
Paul Hudson: FAQ
- What company does Paul Hudson lead?
- Paul Hudson is CEO of Sanofi.
- Where was Paul Hudson educated?
- Paul Hudson studied at Manchester Metropolitan University.
